CLADCOMS- CLADribine tablets long-term Control Of MS - a post-marketing investigator driven study

被引：0

作者：

Larsson, Veronica ^{[1
]}

Nilsson, Petra ^{[2
]}

Magdalena, Lucia Alonso ^{[3
,4
]}

Svenningsson, Anders ^{[5
]}

Gunnarsson, Martin ^{[6
]}

Ayad, Ahmad ^{[7
]}

Vrethem, Magnus ^{[8
]}

Burman, Joachim ^{[9
]}

Lycke, Jan ^{[10
]}

Piehl, Fredrik ^{[1
,11
]}

Fink, Katharina ^{[1
,11
]}

机构：

[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden

[2] Lund Univ, Dept Neurol, Lund, Sweden

[3] Skane Univ, Dept Neurol, Skane Univ Hosp, Skane, Sweden

[4] Lund Univ, Dept Clin Sci, Skane, Sweden

[5] Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden

[6] Orebro Univ, Dept Neurol, Orebro, Sweden

[7] Capio St Goran Hosp, Neurol kliniken, Stockholm, Sweden

[8] Linkoping Univ, Dept Clin & Expt, Linkoping, Sweden

[9] Uppsala Univ, Dept Med Sci, Uppsala, Sweden

[10] Univ Gothenburg, Dept Clin Neurosci, Gothenburg, Sweden

[11] Acad Specialist Ctr, Centrum Neurol, Stockholm, Sweden

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1518/2240

引用

页码：968 / 969

页数：2

共 50 条

[1] CLADCOMS - CLADribine tablets long-term Control Of MS - a post-marketing investigator driven study
Fink, K.
Nilsson, P.
Alonso, L.
Sveningsson, A.
Gunnarsson, M.
Lange, N.
Ayad, A.
Vrethem, M.
Burman, J.
Lycke, J.
Piehl, F.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 847 - 848
[2] P1721/2323 CLADCOMS - CLADribine tablets long-term Control Of MS - a post-marketing investigator driven study
Larsson, Veronica
Forsberg, Linda
Nilsson, Petra
Magdalena, Lucia Alonso
Svenningsson, Anders
Gunnarsson, Martin
Ayad, Ahmad
Mellergard, Johan
Vrethem, Magnus
Burman, Joachim
Lycke, Jan
Piehl, Fredrik
Fink, Katharina
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1088 - 1089
[3] Long-term treatment with flupentixol results of a post-marketing surveillance study
Stecker, G.
Capellen, K. Meyer zur
Glaser, T.
Landen, H.
Messer, T.
Schmauss, M.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 143 - 143
[4] Long-term treatment with flupentixol results of a post-marketing surveillance study
Messer, T.
Glaser, T.
Landen, H.
Schmauss, M.
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (07) : 805 - 813
[5] EFFICACY AND SAFETY OF PIROZADIL IN LONG-TERM ADMINISTRATION - A STUDY OF POST-MARKETING SURVEILLANCE
TAPOUNET, R
MEDICINA CLINICA, 1987, 89 (20): : 858 - 860
[6] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Rie Kanamori
Shiho Yamane
Takeshi Seto
Advances in Therapy, 2021, 38 : 4949 - 4960
[7] Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance Study
Kanamori, Rie
Yamane, Shiho
Seto, Takeshi
ADVANCES IN THERAPY, 2021, 38 (09) : 4949 - 4960
[8] NON-INTERVENTIONAL POST-MARKETING SAFETY STUDY ON THE LONG-TERM SAFETY OF HYQVIA (GLOBAL)
Fielhauer, Katharina
Nagy, Andras
Rabbat, Christopher
McCoy, Barbara
Leibl, Heinz
Yel, Leman
JOURNAL OF CLINICAL IMMUNOLOGY, 2016, 36 (03) : 268 - 268
[9] A NOVEL-APPROACH TO A LONG-TERM POST-MARKETING SURVEILLANCE STUDY, USING MEDICAID BILLING DATA
STROM, BL
CARSON, JL
MORSE, ML
SOPER, KA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 278 - 278
[10] Gene Therapy for Adenosine Deaminase Deficiency: Long-Term Outcome and Post-Marketing Experience
Migliavacca, Maddalena
Barzaghi, Federica
Fossati, Claudia
Rancoita, Paola M. V.
Gabaldo, Michela
Dionisio, Francesca
Giannelli, Stefania
Salerio, Federica Andrea
Ferrua, Francesca
Tucci, Francesca
Calbi, Valeria
Gallo, Vera
Recupero, Salvatore
Consiglieri, Giulia
Cesana, Daniela
Montini, Eugenio
Pajno, Roberta
Monti, Ilaria
Silvani, Paolo
Darin, Silvia
Casiraghi, Miriam
Corti, Ambra
Zancan, Stefano
Levi, Margherita
AbdElaziz, Dalia
Baumann, Ulrich
Finocchi, Andrea
Cancrini, Caterina
Ladogana, Saverio
Meinhardt, Andrea
Meyts, Isabelle
Montin, Davide
Notarangelo, Lucia Dora
Porta, Fulvio
Pasquet, Marlene
Speckmann, Carsten
Stepensky, Polina
Tommasini, Alberto
Rabusin, Marco
Karakas, Zeynep
Galicchio, Miguel
Leonardi, Lucia
Duse, Marzia
Guner, Sukru Nail
Di Serio, Clelia
Ciceri, Fabio
Bernardo, Maria Ester
Aiuti, Alessandro
Cicalese, Maria Pia
MOLECULAR THERAPY, 2023, 31 (04) : 4 - 5

← 1 2 3 4 5 →